The Gillett Health Podcast cover image

Big Pharma | The Gillett Health Podcast #34

The Gillett Health Podcast

CHAPTER

The Problems With Phase Three Trials

After these phase three trials are done that you look at it for approval, there is ways that you can pay for expedited approval. And then after that, as you mentioned, they have the data afterwards, sometimes referred to as stage four. This is where you see sort of breakthrough things or side effects that weren't seen in the trials because the trials may only have, you know, 10,000 people total and even fewer if you go back farther in time.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner